RedHill Biopharma Cash Flow Statement (2011-2025) | RDHL

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Operating Activities
Net Income (Quarter)
11.58M16.45M9.17M10.58M15.15M13.48M20.67M13.45M-145.26M12.74M6.62M-16.62M-78.22M-7.92M80.50M
Depreciation and Depletion (Quarter)
0.25M0.35M0.42M0.47M0.47M0.49M0.47M0.51M0.45M0.54M0.62M0.49M0.49M
Share-based Compensation (Quarter)
0.75M0.80M0.62M1.70M1.08M0.87M5.27M2.19M1.88M2.31M0.62M1.61M1.14M
Gains from Investment Securities (Quarter)
0.12M1.57M0.63M0.53M0.19M0.39M-0.08M4.77M0.82M
Asset Writedowns and Impairment (Quarter)
1.08M1.77M2.11M2.08M1.83M1.83M1.83M10.74M1.60M1.30M1.60M1.52M
Cash from Operations (Quarter)
-13.87M-10.62M-15.03M-9.17M-12.71M-12.27M-18.90M-19.02M-14.86M-4.16M-16.58M-6.03M-2.42M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.26M
Amortization (Quarter)
1.17M4.29M105.24M112.03M6.29M5.88M105.18M5.42M13.75M98.39M166.41M193.53M-2.94M48.44M28.19M19.98M21.23M22.22M22.29M19.22M
Depreciation & Amortization (CF) (Quarter)
0.25M0.35M0.42M0.47M0.47M0.49M0.47M0.51M0.45M0.54M0.62M0.49M0.49M
Change in Working Capital
Change in Receivables (Quarter)
0.09M-0.50M-3.27M6.15M-16.23M5.35M-0.20M-0.39M-1.64M5.74M0.72M-2.25M1.49M
Change in Inventory (Quarter)
0.08M-0.89M-1.98M-0.35M-1.43M-2.74M0.51M-4.35M-1.70M0.54M2.55M-0.86M1.57M
Change in Account Payables (Quarter)
-0.61M-1.00M2.12M1.26M4.98M-5.02M6.77M1.94M-3.58M-5.96M-1.33M0.41M-0.55M
Change in Accured Expenses (Quarter)
-3.81M6.03M17.80M-4.69M1.90M1.36M-2.28M-2.58M0.31M3.25M-2.20M0.99M-3.25M0.46M
Investing Activities
Capital Expenditures (Quarter)
-0.03M-0.24M-0.02M-0.17M-0.05M-0.09M-0.00M-0.02M-0.00M-0.01M-0.16M-0.02M
Change in Intangibles (Quarter)
-52.50M-0.73M
Divestments (Quarter)
-4.90M4.00M1.17M7.85M0.39M-3.50M-8.52M3.50M8.49M-0.16M-0.02M
Cash from Investing Activities (Quarter)
-49.80M-3.50M
Financing Activities
Other financing activities (Quarter)
-20.00M4.00M
Change in Capital Stock
Shares Issued (Quarter)
6.36M9.14M8.37M57.94M0.27M0.50M19.82M0.71M15.51M7.58M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
36.10M59.08M5.46M11.96M7.94M58.66M-1.77M-1.00M17.57M-4.94M14.92M
Exchange Rate Effect (Quarter)
0.05M0.13M0.02M-0.03M0.01M-0.10M0.01M-0.02M0.01M-0.01M-0.03M-0.01M-0.02M
Change in Cash (Quarter)
17.34M52.46M-59.37M3.96M3.09M46.78M-24.17M-28.55M6.21M-0.61M-1.83M-11.77M4.78M
Free Cash Flow (Quarter)
-13.84M-10.38M-15.01M-9.01M-12.66M-12.18M-18.89M-19.00M-14.86M-4.14M-16.42M-6.01M-2.42M
Net Cash Flow (Quarter)
22.23M48.46M-59.37M2.79M-4.76M46.39M-24.17M-20.02M2.71M-9.10M-1.66M-6.03M-2.42M